Skip to main content
. Author manuscript; available in PMC: 2013 Jun 17.
Published in final edited form as: Obesity (Silver Spring). 2011 Nov 10;20(2):364–370. doi: 10.1038/oby.2011.337

Table 2.

Estimated treatment effects within and between study arms.

Outcome Δ Control Δ Exenatide Treatment Effect (95% CI) P-value
BMI (kg/m2) 0.84 (1.28) −0.90 (1.22) −1.71 (−3.01, −0.42) 0.010
Percent BMI 1.72 (4.19) −2.57 (3.46) −4.92 (−8.61, −1.23) 0.009
Weight (kg) 2.97 (2.88) −0.99 (2.90) −3.90 (−7.11, −0.69) 0.017
Percent Weight 2.68 (3.71) −1.20 (3.19) −4.58 (−8.12, −1.04) 0.011
Body Fat (%) 0.92 (2.75) −0.36 (3.07) −1.28 (−4.66, 2.09) 0.457
Heart Rate (bpm) −4.80 (7.45) 2.22 (11.26) 7.60 (−3.01, 18.21) 0.160
SBP (mmHg) 3.10 (8.72) −3.11 (8.51) −5.31 (−14.89, 4.27) 0.277
DBP (mmHg) −0.30 (13.91) −1.78 (11.96) −3.00 (−18.33, 12.33) 0.701
Cholesterol (mg/dL) −8.60 (18.31) 4.33 (19.54) 10.70 (−11.92, 33.32) 0.354
LDL (mg/dL) −4.50 (16.75) 2.89 (16.70) 6.93 (−11.77, 25.62) 0.468
HDL (mg/dL) −0.20 (6.84) 3.44 (3.40) 3.25 (−2.47, 8.97) 0.266
Triglycerides (mg/dL) −4.22 (37.45) −9.89 (41.24) −12.57 (−59.41, 34.28) 0.599
ALT (U/L) 0.89 (10.49) 0.71 (7.63) 1.48 (−10.65, 13.60) 0.811
AST (U/L) −3.67 (3.61) 3.29 (3.64) 6.04 (2.54, 9.54) <0.001
Glucose (mg/dL) 1.60 (6.40) 3.22 (5.85) 1.68 (−3.65, 7.01) 0.537
Glucose AUC (per 100) 11.69 (29.50) −17.67 (22.98) −27.96 (−56.51, 0.59) 0.055
Insulin (mU/L) 6.00 (5.58) −1.62 (8.42) −7.54 (−13.71, −1.37) 0.017
Insulin AUC (per 100) 30.29 (98.76) −38.95 (73.74) −76.01 (−166.30, 14.28) 0.099
WBISI/Matuda −2.00 (3.52) 4.12 (7.10) 6.13 (1.01, 11.25) 0.019
β-Cell Function −1.16 (6.33) 14.50 (26.09) 17.97 (1.40, 34.54) 0.034
CRP (mg/L) −0.50 (0.76) −0.36 (1.66) 0.12 (−1.11, 1.34) 0.853
IL-6 (pg/mL) −0.54 (0.78) −0.83 (1.62) −0.35 (−1.21, 0.50) 0.419
TNF-a (pg/mL) −0.16 (0.49) −0.33 (0.67) −0.17 (−0.82, 0.48) 0.610
Adiponectin (μg/mL) −1.35 (5.47) −0.20 (3.93) 0.98 (−4.22, 6.17) 0.712
Leptin (ng/mL) −7.95 (41.31) −12.71 (22.02) −4.44 (−40.29, 31.41) 0.808
OxLDL (U/L) −0.73 (7.49) −0.40 (5.02) 0.34 (−5.44, 6.13) 0.907
VCAM-1 (ng/mL) 73.31 (154.41) −7.37 (142.68) −79.33 (−252.28, 93.63) 0.369
vWF (U/mL) −3.81 (11.24) −2.17 (10.87) 2.08 (−10.97, 15.12) 0.755
RHI 0.23 (0.65) −0.03 (0.69) −0.26 (−0.88, 0.36) 0.413

Values presented are mean (SD).